Droloxifene

This classification denotes a selective estrogen receptor modulator with the molecular formula C26H29NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0M67U6Z98F, chemically known as phenol, 3-(1-(4-(2-(dimethylamino)ethoxy)phenyl)-2-phenyl-1-butenyl)-, (e)- but more generally known as droloxifene, which bears US NIH Compound Identifier 3033767. European Medicines Agency schedules Droloxifene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06405MIG. The term DROLOXIFENE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). DROLOXIFENE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule droloxifene under HS 29221980 and SITC 51461. As of Q4 2014, DROLOXIFENE remains US FDA's Preferred Term for this commodity. Droloxifene bears US NLM identifiers UMLS ID C0047498 and NCI Concept Code C969. SMILES: O(C1CCC(/C(=C(/CC)C2CCCCC2)C2CC(O)CCC2)CC1)CCN(C)C.